"MM-PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID6182104598

KRS0000332849

Share capital50,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. METALOWCÓW 39, 62-800 KALISZ

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

"MM-PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. METALOWCÓW 39, 62-800 KALISZ

Show on map

NIP

6182104598

REGON

301142508

KRS

0000332849

Legal form

limited liability company

Register Address

UL. METALOWCÓW 39, 62-800 KALISZ

Date of registration in KRS

2009-07-07

Date of commencement of economic activity

2009-07-07

Act signature

PO.IX NS-REJ.KRS/6953/20/145/ADE

Pkd codes

47.73.Z - Retail sale of pharmaceutical products

21.10.Z - Manufacture of basic pharmaceutical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

47.29.Z - Retail trade

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

47.78.Z - Retail sale of other new products

49.41.Z - Road freight transport

68.10.Z - Real estate activities on own account and development of building projects

68.20.Z - Rental and management of own or leased real estate

Payer VAT status

Active

Vat list bank account(s)

PL13 1020 3668 0000 5902 0433 4322

PL09 1160 2202 0000 0001 4372 5348

Company authorities

representation authorityMANAGEMENT

representation type

DO REPREZENTOWANIA SPÓŁKI W STOSUNKACH ZEWNĘTRZNYCH UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU JEDNOOSOBOWO.

MANAGEMENT

Monika Smolarek

Vice President, 49 years old

Krzysztof Rafał Szelc

Chairman Of The Board, 46 years old

shareholders

Monika Smolarek

50% 50 udziałów o łącznej wysokości 25.000,00 zł

Krzysztof Rafał Szelc

50% 50 udziałów o łącznej wysokości 25.000,00 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	0,5	-0,1	-0,9	-854,2
EBITDA	0,7	0,2	-0,7	-522,3
Short time liabilities	3,4	3,1	3	-2,6
Equity capital	3,8	3,8	2,9	-21,7
Operating profit (EBIT)	0,4	-0,1	-0,9	-787,1
Assets	7,6	7,1	6	-15,2
Net profit (loss)	0,5	-0,1	-0,8	-958,2
Cash	2	2,1	1,4	-34,8
Net income from sale	23,4	22,5	21	-6,9
Liabilities and provisions for liabilities	3,8	3,3	3,1	-7,8
Working assets	6,8	6,5	5,6	-13,2
Depreciation	0,2	0,3	0,2	-38,9
	%	%	%	p.p.
Profitability of capital	11,8	-2,1	-27,8	-25,7
Equity capital to total assets	50,5	52,9	48,8	-4,1
Gross profit margin	2	-0,4	-4,3	-3,9
EBITDA Margin	2,8	0,8	-3,5	-4,3
	Days	Days	Days	Days
Short term commitment turnover cycle	53	50	53	3